About 2 results found for searched term "Brentuximab" (0.061 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24906 | Brentuximab | TNF Receptor |
| Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies. | ||
| M25284 | Brentuximab vedotin | Drug-Linker Conjugates for ADC |
| Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). Brentuximab vedotin inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
